25 XP   0   0   10

CannaPharmaRx Inc
Buy, Hold or Sell?

Let's analyse Cannapharmarx together

PenkeI guess you are interested in CannaPharmaRx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of CannaPharmaRx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about CannaPharmaRx Inc

I send you an email if I find something interesting about CannaPharmaRx Inc.

Quick analysis of Cannapharmarx (30 sec.)










What can you expect buying and holding a share of Cannapharmarx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
$-0.05
Expected worth in 1 year
$-0.05
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
$0.01
Expected price per share
$0.01 - $0.0279
How sure are you?
50%

1. Valuation of Cannapharmarx (5 min.)




Live pricePrice per Share (EOD)

$0.01

Intrinsic Value Per Share

$-0.08 - $-0.02

Total Value Per Share

$-0.13 - $-0.07

2. Growth of Cannapharmarx (5 min.)




Is Cannapharmarx growing?

Current yearPrevious yearGrowGrow %
How rich?-$17.3m-$17.3m0.000.0%

How much money is Cannapharmarx making?

Current yearPrevious yearGrowGrow %
Making money-$8.5m-$8.5m0.000.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Cannapharmarx (5 min.)




What can you expect buying and holding a share of Cannapharmarx? (5 min.)

Welcome investor! Cannapharmarx's management wants to use your money to grow the business. In return you get a share of Cannapharmarx.

What can you expect buying and holding a share of Cannapharmarx?

First you should know what it really means to hold a share of Cannapharmarx. And how you can make/lose money.

Speculation

The Price per Share of Cannapharmarx is $0.014. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cannapharmarx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cannapharmarx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.05. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cannapharmarx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.03-180.3%-0.03-180.3%-0.03-180.3%-0.04-280.0%-0.03-181.9%
Usd Book Value Change Per Share0.000.0%0.000.0%-0.01-93.4%-0.01-70.4%-0.01-36.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.0012.1%0.006.1%
Usd Total Gains Per Share0.000.0%0.000.0%-0.01-93.4%-0.01-58.3%0.00-30.0%
Usd Price Per Share0.00-0.00-0.01-0.35-0.92-
Price to Earnings Ratio-0.07--0.07--0.40--6.02--2,866.53-
Price-to-Total Gains Ratio-0.76-9.18-23,156.46-
Price to Book Ratio-0.03--0.03--0.19-13.67--531.71-
Price-to-Total Gains Ratio-0.76-9.18-23,156.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.014
Number of shares71428
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.01
Usd Total Gains Per Share0.00-0.01
Gains per Quarter (71428 shares)0.00-583.11
Gains per Year (71428 shares)0.00-2,332.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
100-10484-2817-2342
200-10969-5634-4674
300-101453-8451-7006
400-101938-11267-9338
500-102422-14084-11670
600-102906-16901-14002
700-103391-19718-16334
800-103875-22535-18666
900-104360-25352-20998
1000-104844-28169-23330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%4.016.00.020.0%
Book Value Change Per Share0.00.01.00.0%0.02.01.00.0%1.03.01.020.0%3.06.01.030.0%8.011.01.040.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%2.00.03.040.0%2.00.08.020.0%3.00.017.015.0%
Total Gains per Share0.00.01.00.0%0.02.01.00.0%1.03.01.020.0%3.06.01.030.0%8.011.01.040.0%

Fundamentals of Cannapharmarx

About CannaPharmaRx Inc

CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

Fundamental data was last updated by Penke on 2024-05-15 21:40:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of CannaPharmaRx Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cannapharmarx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cannapharmarx to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CannaPharmaRx Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.1.2. Return on Assets

Shows how efficient Cannapharmarx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cannapharmarx to the Drug Manufacturers - Specialty & Generic industry mean.
  • -157.6% Return on Assets means that Cannapharmarx generated $-1.58 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CannaPharmaRx Inc:

  • The MRQ is -157.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -157.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-157.6%TTM-157.6%0.0%
TTM-157.6%YOY-157.6%0.0%
TTM-157.6%5Y-1,953.6%+1,796.1%
5Y-1,953.6%10Y-26,520.8%+24,567.2%
1.1.3. Return on Equity

Shows how efficient Cannapharmarx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cannapharmarx to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Cannapharmarx generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CannaPharmaRx Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-102.7%+102.7%
5Y-102.7%10Y-51.3%-51.3%

1.2. Operating Efficiency of CannaPharmaRx Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cannapharmarx is operating .

  • Measures how much profit Cannapharmarx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cannapharmarx to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CannaPharmaRx Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Cannapharmarx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CannaPharmaRx Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000

1.3. Liquidity of CannaPharmaRx Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cannapharmarx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.01 means the company has $0.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CannaPharmaRx Inc:

  • The MRQ is 0.006. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.006. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.006TTM0.0060.000
TTM0.006YOY0.0060.000
TTM0.0065Y0.106-0.100
5Y0.10610Y0.142-0.036
1.3.2. Quick Ratio

Measures if Cannapharmarx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cannapharmarx to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CannaPharmaRx Inc:

  • The MRQ is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.0010.000
TTM0.001YOY0.001+0.000
TTM0.0015Y0.073-0.071
5Y0.07310Y0.119-0.047

1.4. Solvency of CannaPharmaRx Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cannapharmarx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cannapharmarx to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 4.20 means that Cannapharmarx assets are financed with 420.4% credit (debt) and the remaining percentage (100% - 420.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CannaPharmaRx Inc:

  • The MRQ is 4.204. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 4.204. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.204TTM4.2040.000
TTM4.204YOY4.2040.000
TTM4.2045Y25.034-20.830
5Y25.03410Y139.581-114.547
1.4.2. Debt to Equity Ratio

Measures if Cannapharmarx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cannapharmarx to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CannaPharmaRx Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.460-0.460
5Y0.46010Y0.230+0.230

2. Market Valuation of CannaPharmaRx Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cannapharmarx generates.

  • Above 15 is considered overpriced but always compare Cannapharmarx to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -0.07 means the investor is paying $-0.07 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CannaPharmaRx Inc:

  • The EOD is -0.555. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.067. Based on the earnings, the company is expensive. -2
  • The TTM is -0.067. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.555MRQ-0.067-0.487
MRQ-0.067TTM-0.0670.000
TTM-0.067YOY-0.396+0.329
TTM-0.0675Y-6.022+5.954
5Y-6.02210Y-2,866.527+2,860.505
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CannaPharmaRx Inc:

  • The EOD is -3.025. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.367. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.367. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.025MRQ-0.367-2.657
MRQ-0.367TTM-0.3670.000
TTM-0.367YOY-2.160+1.793
TTM-0.3675Y-81.806+81.438
5Y-81.80610Y-360.367+278.562
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cannapharmarx is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of CannaPharmaRx Inc:

  • The EOD is -0.273. Based on the equity, the company is expensive. -2
  • The MRQ is -0.033. Based on the equity, the company is expensive. -2
  • The TTM is -0.033. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.273MRQ-0.033-0.240
MRQ-0.033TTM-0.0330.000
TTM-0.033YOY-0.195+0.162
TTM-0.0335Y13.668-13.701
5Y13.66810Y-531.710+545.378
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of CannaPharmaRx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%-0.0130%-0.0100%-0.0050%
Book Value Per Share---0.051-0.0510%-0.0510%-0.031-41%-0.016-68%
Current Ratio--0.0060.0060%0.0060%0.106-94%0.142-96%
Debt To Asset Ratio--4.2044.2040%4.2040%25.034-83%139.581-97%
Debt To Equity Ratio----0%-0%0.460-100%0.230-100%
Dividend Per Share----0%-0%0.002-100%0.001-100%
Eps---0.025-0.0250%-0.0250%-0.039+55%-0.025+1%
Free Cash Flow Per Share---0.005-0.0050%-0.0050%-0.006+27%-0.005+14%
Free Cash Flow To Equity Per Share--0.0000.0000%0.0000%-0.001+115%-0.001+53%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.019--------
Intrinsic Value_10Y_min---0.080--------
Intrinsic Value_1Y_max---0.005--------
Intrinsic Value_1Y_min---0.006--------
Intrinsic Value_3Y_max---0.012--------
Intrinsic Value_3Y_min---0.021--------
Intrinsic Value_5Y_max---0.016--------
Intrinsic Value_5Y_min---0.037--------
Market Cap4731453.888+88%574533.686574533.6860%3379609.920-83%119955874.500-100%310069071.330-100%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-0.273-724%-0.033-0.0330%-0.195+488%13.668-100%-531.710+1605066%
Pe Ratio-0.555-724%-0.067-0.0670%-0.396+488%-6.022+8841%-2866.527+4256290%
Price Per Share0.014+88%0.0020.0020%0.010-83%0.355-100%0.917-100%
Price To Free Cash Flow Ratio-3.025-724%-0.367-0.3670%-2.160+488%-81.806+22174%-360.367+98022%
Quick Ratio--0.0010.0010%0.001+10%0.073-98%0.119-99%
Return On Assets---1.576-1.5760%-1.5760%-19.536+1140%-265.208+16731%
Return On Equity----0%-0%-1.0270%-0.5130%
Total Gains Per Share----0%-0.0130%-0.0080%-0.0040%
Usd Book Value---17344455.000-17344455.0000%-17344455.0000%-10312446.200-41%-5513984.500-68%
Usd Book Value Change Per Share----0%-0.0130%-0.0100%-0.0050%
Usd Book Value Per Share---0.051-0.0510%-0.0510%-0.031-41%-0.016-68%
Usd Dividend Per Share----0%-0%0.002-100%0.001-100%
Usd Eps---0.025-0.0250%-0.0250%-0.039+55%-0.025+1%
Usd Free Cash Flow---1564362.000-1564362.0000%-1564362.0000%-1990984.800+27%-1775581.500+14%
Usd Free Cash Flow Per Share---0.005-0.0050%-0.0050%-0.006+27%-0.005+14%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.0000%-0.001+115%-0.001+53%
Usd Market Cap4731453.888+88%574533.686574533.6860%3379609.920-83%119955874.500-100%310069071.330-100%
Usd Price Per Share0.014+88%0.0020.0020%0.010-83%0.355-100%0.917-100%
Usd Profit---8531020.000-8531020.0000%-8531020.0000%-14902055.400+75%-10298245.700+21%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share----0%-0.0130%-0.0080%-0.0040%
 EOD+6 -1MRQTTM+0 -0YOY+2 -65Y+13 -1210Y+12 -13

3.2. Fundamental Score

Let's check the fundamental score of CannaPharmaRx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.555
Price to Book Ratio (EOD)Between0-1-0.273
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.001
Current Ratio (MRQ)Greater than10.006
Debt to Asset Ratio (MRQ)Less than14.204
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.576
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of CannaPharmaRx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.397
Ma 20Greater thanMa 500.010
Ma 50Greater thanMa 1000.013
Ma 100Greater thanMa 2000.009
OpenGreater thanClose0.012
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets5,414
Total Liabilities22,759
Total Stockholder Equity-17,344
 As reported
Total Liabilities 22,759
Total Stockholder Equity+ -17,344
Total Assets = 5,414

Assets

Total Assets5,414
Total Current Assets100
Long-term Assets5,314
Total Current Assets
Cash And Cash Equivalents 2
Net Receivables 23
Inventory 69
Other Current Assets 6
Total Current Assets  (as reported)100
Total Current Assets  (calculated)100
+/-0
Long-term Assets
Property Plant Equipment 5,235
Long-term Assets  (as reported)5,314
Long-term Assets  (calculated)5,235
+/- 79

Liabilities & Shareholders' Equity

Total Current Liabilities17,165
Long-term Liabilities5,593
Total Stockholder Equity-17,344
Total Current Liabilities
Short-term Debt 8,931
Accounts payable 6,883
Other Current Liabilities 1,009
Total Current Liabilities  (as reported)17,165
Total Current Liabilities  (calculated)16,823
+/- 342
Long-term Liabilities
Long-term Liabilities  (as reported)5,593
Long-term Liabilities  (calculated)0
+/- 5,593
Total Stockholder Equity
Common Stock27
Retained Earnings -94,695
Accumulated Other Comprehensive Income 240
Other Stockholders Equity 74,524
Total Stockholder Equity (as reported)-17,344
Total Stockholder Equity (calculated)-19,904
+/- 2,559
Other
Cash and Short Term Investments 2
Common Stock Shares Outstanding 211,044
Current Deferred Revenue342
Liabilities and Stockholders Equity 5,414
Net Debt 14,523
Net Working Capital -17,065
Short Long Term Debt Total 14,525



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-311999-12-311998-12-31
> Total Assets 
2,270
9,600
0
6
0
0
0
0
0
0
1,797
12
2
0
12
16,017
8,748
114
5,414
5,414
5,4145,4141148,74816,0171202121,797000000609,6002,270
   > Total Current Assets 
20
4,590
0
6
0
-200
0
0
0
0
1,649
12
2
0
12
1,931
468
30
100
100
100100304681,9311202121,6490000-2000604,59020
       Cash And Cash Equivalents 
20
4,350
0
6
0
-200
0
0
0
0
1,605
3
0
0
3
2
335
28
2
2
2228335230031,6050000-2000604,35020
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,309
0
0
0
0
00001,309000000000000000
       Net Receivables 
0
90
0
0
0
0
0
0
0
0
0
0
0
0
0
28
1
2
23
23
232321280000000000000900
       Other Current Assets 
0
150
0
0
0
0
0
0
0
0
44
0
0
0
9
1,930
133
2
6
6
6621331,930900044000000001500
   > Long-term Assets 
2,250
5,010
0
0
0
0
0
0
0
0
148
0
0
0
9,499
14,086
8,280
85
5,314
5,314
5,3145,314858,28014,0869,499000148000000005,0102,250
       Property Plant Equipment 
0
670
0
0
0
0
0
0
0
0
98
0
0
0
1,563
1,688
1,569
6
5,235
5,235
5,2355,23561,5691,6881,56300098000000006700
       Goodwill 
0
3,890
0
0
0
0
0
0
0
0
0
0
0
0
6,065
6,370
0
0
0
0
00006,3706,0650000000000003,8900
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,194
6,711
79
79
0
079796,7114,194000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,871
1,834
0
0
0
0
00001,8341,87100000000000000
       Long-term Assets Other 
2,250
450
0
0
0
0
0
0
0
0
50
0
0
0
9,499
1,688
0
0
0
0
00001,6889,49900050000000004502,250
> Total Liabilities 
290
2,430
7,946
591
685
576
0
100
198
292
2,085
697
959
964
697
11,163
17,549
13,040
22,759
22,759
22,75922,75913,04017,54911,1636979649596972,08529219810005766855917,9462,430290
   > Total Current Liabilities 
30
2,050
7,946
591
685
576
0
100
198
292
1,940
697
959
964
697
3,952
17,549
13,040
17,165
17,165
17,16517,16513,04017,5493,9526979649596971,94029219810005766855917,9462,05030
       Short-term Debt 
0
140
4,508
408
242
300
0
72
143
214
1,803
0
20
20
20
2,071
10,001
9,019
0
8,931
8,93109,01910,0012,07120202001,8032141437203002424084,5081400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
143
214
1,803
0
20
20
4,779
2,071
10,001
9,019
8,931
0
08,9319,01910,0012,0714,779202001,80321414300000000
       Accounts payable 
0
0
1,710
94
150
175
0
25
44
52
138
457
600
605
457
903
2,448
3,129
6,883
6,883
6,8836,8833,1292,4489034576056004571385244250175150941,71000
       Other Current Liabilities 
30
1,910
1,085
89
196
102
0
3
11
26
1,803
190
190
190
240
978
3,677
507
1,199
1,009
1,0091,1995073,6779782401901901901,803261130102196891,0851,91030
   > Long-term Liabilities 
260
380
0
210
0
0
0
0
0
0
145
0
0
0
0
7,211
12,449
0
5,593
5,593
5,5935,593012,4497,21100001450000002100380260
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
145
0
0
0
0
0
0
0
0
0
0000000001450000000000
> Total Stockholder Equity
1,990
7,170
-7,946
-585
-685
-576
0
-100
-198
-292
-288
-685
-958
-964
-685
4,854
-8,802
-12,926
-17,344
-17,344
-17,344-17,344-12,926-8,8024,854-685-964-958-685-288-292-198-1000-576-685-585-7,9467,1701,990
   Common Stock
0
200
1
1
1
1
0
0
0
0
2
2
2
2
2
4
5
13
27
27
2727135422222000011112000
   Retained Earnings -94,695-94,695-86,164-77,332-57,442-32,888-33,896-33,890-32,888-21,145-17,167-17,073-16,974-16,875-17,450-17,559-17,357-24,471-4,850-40
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
2,030
11,870
16,524
16,771
16,873
16,873
16,875
16,875
16,875
16,875
20,905
0
0
0
32,202
61,619
68,336
73,056
240
74,524
74,52424073,05668,33661,61932,20200020,90516,87516,87516,87516,87516,87316,87316,77116,52411,8702,030



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.